(Q37696967)

22 August 2017

1 reference

title

Cell therapy for the treatment of coronary heart disease: a critical appraisal (English)

1 reference

22 August 2017

1 reference

coronary artery disease

1 reference

Kai C Wollert

1

1 reference

PubMed ID

20177405

22 August 2017

Helmut Drexler

series ordinal

2

1 reference

PubMed ID

20177405

22 August 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

Nature Reviews Cardiology

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

4

1 reference

22 August 2017

204-215

1 reference

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Parthenotes as a source of embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Long-term trends in the incidence of heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Systems approaches to preventing transplanted cell death in cardiac repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Cardiogenesis and the complex biology of regenerative cardiovascular medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Myocyte and myogenic stem cell transplantation in the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

The evolving concept of a stem cell: entity or function?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Plasticity of adult stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Clinical applications of stem cells for the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Myoblast transplantation for heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Skeletal myoblasts as a therapeutic agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Stem cell therapy for heart failure: are arrhythmias a real safety concern?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Transcoronary transplantation of progenitor cells after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Methods of stem cell delivery in cardiac diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Delivery of Biologics in Cardiovascular Regenerative Medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

X-ray fused with magnetic resonance imaging (XFM) to target endomyocardial injections: validation in a swine model of myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Monitoring of bone marrow cell homing into the infarcted human myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Skeletal myoblasts and cardiac repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Circulating endothelial progenitor cells and cardiovascular outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Aging and disease as modifiers of efficacy of cell therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Homing and engraftment of progenitor cells: a prerequisite for cell therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Importance of the SDF-1:CXCR4 axis in myocardial repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Activation of Epac stimulates integrin-dependent homing of progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Mechanisms of activation and regulation of the heat shock-sensitive signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Can Cold or Heat Shock Improve Skeletal Myoblast Engraftment in Infarcted Myocardium?

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

31 March 2020

12 December 2020

Genetic enhancement of stem cell engraftment, survival, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Development of bioactive peptide amphiphiles for therapeutic cell delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Custom design of the cardiac microenvironment with biomaterials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Mesenchymal stem cells for myocardial infarction: promises and pitfalls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Unraveling the mechanistic basis of mesenchymal stem cell activity in the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Working hypothesis to redefine endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Paracrine mechanisms in adult stem cell signaling and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells an

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Interleukin-10 From Transplanted Bone Marrow Mononuclear Cells Contributes to Cardiac Protection After Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Quantitative proteomics analysis of the secretory pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Pluripotency of spermatogonial stem cells from adult mouse testis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Generation of pluripotent stem cells from adult human testis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Origins and fates of cardiovascular progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Induced pluripotent stem cell lines derived from human somatic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Generation of functional murine cardiac myocytes from induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Reprogramming of murine and human somatic cells using a single polycistronic vector

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Genetic control of wayward pluripotent stem cells and their progeny after transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.1

Recent advances in protein and peptide drug delivery systems

31 March 2020

1 reference

12 December 2020

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction

1 reference

12 December 2020

Multipotent adult progenitor cells sustain function of ischemic limbs in mice.

1 reference

12 December 2020

Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2010.1

1 reference

22 August 2017

1 reference

PubMed ID

20177405